Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.14T
Market cap1.14T
Price-Earnings ratio
40.59
Price-Earnings ratio40.59
Dividend yield
0.57%
Dividend yield0.57%
Average volume
3.44M
Average volume3.44M
High today
$1,221.00
High today$1,221.00
Low today
$1,122.22
Low today$1,122.22
Open price
$1,130.86
Open price$1,130.86
Volume
7.73M
Volume7.73M
52 Week high
$1,221.00
52 Week high$1,221.00
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

With a market cap of 1.14T, Eli Lilly(LLY) trades at $1,211.10. The stock has a price-to-earnings ratio of 40.59 and currently yields dividends of 0.57%.

On 2026-06-26, Eli Lilly(LLY) stock moved within a range of $1,122.22 to $1,221.00. With shares now at $1,211.10, the stock is trading +7.9% above its intraday low and -0.8% below the session's peak.

Trading activity shows a volume of 7.73M, compared to an average daily volume of 3.44M.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,221.00 and a low of $623.78.

Over the past 52 weeks, Eli Lilly(LLY) stock has traded between a high of $1,221.00 and a low of $623.78.

LLY News

Nasdaq 1h
Is Eli Lilly Stock an Undervalued Healthcare Stock to Buy?

Eli Lilly (NYSE: LLY) is benefiting from its blockbuster weight loss treatment. Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double D...

Is Eli Lilly Stock an Undervalued Healthcare Stock to Buy?
Nasdaq 2h
Why Eli Lilly Stock Jumped to a New All-Time High Today

Key Points Eli Lilly's leukemia drug is making progress toward regulatory approval in the EU. The healthcare leader's weight-loss drugs will soon be more affo...

Why Eli Lilly Stock Jumped to a New All-Time High Today
Nasdaq 5h
Better Buy in the Obesity Drug Race: Novo Nordisk or Eli Lilly?

Key Points Eli Lilly leads in next‑gen obesity drugs, while Novo Nordisk offers a cheaper, dividend‑paying alternative. Novo’s steady insulin cash flows and n...

Better Buy in the Obesity Drug Race: Novo Nordisk or Eli Lilly?

Analyst ratings

84%

of 31 ratings
Buy
83.9%
Hold
9.7%
Sell
6.5%

More LLY News

Simply Wall St 5h
Eli Lilly Could Be 24% Undervalued If Its Growth Narrative Holds

Eli Lilly (LLY) is back in focus for investors after its recent share performance, with the stock closing at $1,127.69 and sitting within a large pharmaceutical...

Eli Lilly Could Be 24% Undervalued If Its Growth Narrative Holds
MarketWatch 7h
Healthcare stocks have become a haven for investors ditching tech

Shares of AbbVie, Eli Lilly and Johnson & Johnson were on track to hit all-time highs Friday, in the latest signal that investor appetite for the biopharmaceuti...

Healthcare stocks have become a haven for investors ditching tech
TipRanks 9h
Eli Lilly Expands Donanemab Alzheimer’s Trial Into China, Targeting Preclinical Patients

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium...

TipRanks 9h
Lilly Ends Early-Stage Prostate Cancer Combo Trial, Nudging Investor Focus Back to Core Oncology Assets

Eli Lilly And Company (LLY) announced an update on their ongoing clinical study. Unlock powerful investing tools and data-driven insights with TipRanks Premium...

TipRanks 11h
Here’s Why Eli Lilly Stock Is Up 6% Today

Eli Lilly’s (LLY) stock is up 6% on June 26 after European regulators backed the company’s new cancer drug called Jaypirca (Pirtobrutinib). Unlock powerful inv...

Nasdaq 13h
Lilly's Jaypirca Receives Positive CHMP Opinion For EU Approval In Chronic Lymphocytic Leukemia

(RTTNews) - Eli Lilly and Co. (LLY, LLY.DE) on Friday announced that the European Medicines Agency's Committee for Medicinal Products for Human Use, or CHMP, is...

Lilly's Jaypirca Receives Positive CHMP Opinion For EU Approval In Chronic Lymphocytic Leukemia
Nasdaq 14h
Fidelity vs. iShares: Which Healthcare ETF Delivers Better Value?

Key Points iShares Global Healthcare ETF provides exposure to international markets, while Fidelity MSCI Health Care Index ETF focuses exclusively on U.S.-base...

Fidelity vs. iShares: Which Healthcare ETF Delivers Better Value?

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.